Nexalin Technology, Inc.(NXL)Earnings, Financials & Key RatiosNexalin Technology, Inc. (NXL) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's $1.2M cash position is insufficient to cover its historical quarterly burn rate, creating a high probability of near-term dilutive financing.
Nexalin Technology, Inc. (NXL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Nexalin Technology, Inc. (NXL) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 8, 2026 | $0.11vs $0.10-10.0% | $14,950vs $15,000-0.3% |
| Q2 2026 | Mar 25, 2026 | $0.13vs $0.12-8.3% | $172,000vs $80,000+115.0% |
| Q4 2025 | Nov 14, 2025 | $0.13vs $0.12-8.3% | $18,149vs $40,000-54.6% |
| Q3 2025 | Aug 6, 2025 | $0.10vs $0.10+0.0% | $70,588vs $71,000-0.6% |
Recent stock market news and headlines for Nexalin Technology, Inc. (NXL)
Dr. Victor Fontenelle Bastos de Lima, an investigator on Nexalin's recently completed Brazilian clinical study, received the Young Researcher Award at BRAIN 2026 – Congress on Brain, Behavior and Emotions, held in Porto Alegre, Brazil
Accepted abstracts showcase Nexalin's proprietary DIFS™ 15 mA 77.5 Hz treatment platform and clinical improvements across anxiety, depression, insomnia and quality of life
Key metrics vs top competitors for Nexalin Technology, Inc. (NXL)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.35 | $7.24M | -0.70 | 78.78% | -2725.76% | -221.5% | — | |
| $7.91 | $65.62M | -4.79 | 27.2% | -44.08% | — | — | |
| $1.35 | $93.94M | -2.29 | 99.17% | -24.48% | -139.83% | — | |
| $83.58 | $4.59B | -18.78 | 10.74% | 7.47% | 9.13% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — | |
| $22.25 | $1.64B | 6.74 | 18.52% | 118.91% | 47.59% | — |
Nexalin Technology, Inc. (NXL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Nexalin Technology, Inc. (NXL) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jun 17, 2026·SEC
May 19, 2026·SEC
Apr 22, 2026·SEC
Get notified when NXL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Nexalin Technology, Inc. (NXL) stock FAQ — growth, dividends, profitability & financials explained
Nexalin Technology, Inc. (NXL) reported $0.3M in revenue for fiscal year 2025. This represents a 33% increase from $0.2M in 2019.
Nexalin Technology, Inc. (NXL) grew revenue by 78.8% over the past year. This is strong growth.
Nexalin Technology, Inc. (NXL) reported a net loss of $8.3M for fiscal year 2025.
Nexalin Technology, Inc. (NXL) has a return on equity (ROE) of -221.5%. Negative ROE indicates the company is unprofitable.
Nexalin Technology, Inc. (NXL) had negative free cash flow of $5.3M in fiscal year 2025, likely due to heavy capital investments.
